# FDA recall D-0719-2022

> **Olympia Compounding Pharmacy dba Olympia Pharmacy** · Class II · drug recall initiated 2022-03-08.

## Product

NAD+ Nicotinamide Adenine Dinucleotide, Lyophilized powder for reconstitution, Multi-Dose 500 mg per vial, Each ML contains: 0.288% Sodium Phosphate Monobasic USP, 0.42% Sodium Phosphate Dibasic USP, 5% Mannitol USP, Sterile Water for Injection USP, Rx Only, Olympia Pharmaceuticals 6700 Conroy Rd., Ste. 155, Orlando, FL 32835 NDC: 73198-0083-00

## Reason for recall

Product found to be Sub Potent or Exceeded reconstitution time

## Distribution

Nationwide in the USA including Puerto Rico.

## Key facts

- **Recall number:** D-0719-2022
- **Recalling firm:** Olympia Compounding Pharmacy dba Olympia Pharmacy
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2022-03-08
- **Report date:** 2022-03-30
- **Termination date:** 2023-10-04

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Orlando, FL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0719-2022

## Citation

> AI Analytics. FDA recall D-0719-2022. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-0719-2022. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*